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222
Background: Major depressive disorder (MDD) is associated with an increased risk of brain atrophy,
223
aging-related diseases, and mortality. We examined potential advanced brain aging in MDD patients, and 224 whether this process is associated with clinical characteristics in a large multi-center international dataset.
225
Methods: We performed a mega-analysis by pooling brain measures derived from T1-weighted MRI 226 scans from 29 samples worldwide. Normative brain aging was estimated by predicting chronological age
227
(10-75 years) from 7 subcortical volumes, 34 cortical thickness and 34 surface area, lateral ventricles and 228 total intracranial volume measures separately in 1,147 male and 1,386 female controls from the ENIGMA 229 MDD working group. The learned model parameters were applied to 1,089 male controls and 1,167 230 depressed males, and 1,326 female controls and 2,044 depressed females to obtain independent 231 unbiased brain-based age predictions. The difference between predicted "brain age" and chronological
232
age was calculated to indicate brain predicted age difference (brain-PAD). 
240
Longitudinal studies of MDD and somatic health outcomes are needed to further assess the predictive 241 value of these brain-PAD estimates.
242
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Research in context 249
Evidence before this study
250
Accumulating evidence from studies suggests that, at the group level, MDD patients follow advanced 251 aging trajectories, as their functional (e.g. walking speed, hand grip strength) and biological state (e.g.
252
telomeres, epigenetics, mitochondria) reflects what is normally expected at an older age (i.e. biological 253 age "outpaces" chronological age). While subtle structural brain abnormalities have been identified in 254 MDD, it remains to be elucidated whether patients also deviate from the normal aging process at the 
262
whether a diagnosis of MDD is associated with the multivariate metric of brain aging in a large dataset,
263
and which clinical characteristics further impact this metric, remains elusive.
265
Added value of this study
266
To our knowledge, this is the first study to examine deviations of normative brain aging in MDD and 267 associated clinical heterogeneity in a large international and multi-center dataset, by pooling data from 268 >8,000 subjects from 29 research samples worldwide. The current study shows that chronological age 269 can be predicted from gray matter features in a large heterogeneous dataset with an age range covering 270 almost the entire lifespan (10-75 years). Moreover, we show that our brain age prediction model 271 generalizes to unseen hold-out samples, as well as to completely independent samples from different 272 scanning sites. We found that, at the group level, patients had, on average, a +0.90 years greater 273 discrepancy between their predicted and actual age compared to control participants and there was a 274 subtle relationship between self-reported symptom severity and advanced brain aging in the MDD group.
275
Finally, the strongest effects were observed in patients with a late onset of depression (>55 years old; 
368
Training and test samples
369
An overview of the data partition is shown in figure 1A and described in more detail in the appendix. 
387
ICV, intracranial volume; SVR, support vector regression.
11
Image processing and analysis
389
Structural T1-weighted scans of each subject were acquired at each site and analyzed locally using 
576
Discussion 577
578
Using a brain age algorithm based on commonly used brain measures derived from T1-weighted scans 579 from over 3,500 males and 4,900 females, we found subtle age-associated gray matter differences in 580 major depressive disorder (MDD). At the group level, the brain age model predicted chronological age in 581 controls and MDD patients from 77 brain morphometric features, and patients had, on average, a 0.90 582 years greater discrepancy between their predicted and actual age compared to control participants.
583
Strongest effects were observed in late-life onset of depression (+1.7y, d=0.17), currently depressed 584 (+1.2y, d=0.13), and first episode MDD (+1.2y, d=0.12) patients, compared to controls. Finally, each one-585 point increase in self-reported symptom severity score at study inclusion added, on average, 18 days of 586 brain aging, potentially underscoring the importance of reducing the number of symptoms in the treatment 587 of depression.
589
The positive association between brain aging and symptom severity, measured with the self-report BDI-II 590 questionnaire, was not confirmed using the clinician-based HDRS-17. Post-hoc analyses in overlapping 591 samples with both scores (N=1,302) yielded a significant correlation between them (r=0.67, p<0.0001),
592
yet the same discrepant association with brain-PAD. This could perhaps be explained by the differential 593 proportion of items emphasizing cognitive and affective (BDI-II) or somatic and behavioral dimensions 594 (HDRS-17).
29 Alternatively, brain age may be more sensitive to subjective (BDI) than to objectively
595
(HDRS-17) rated experiences, consistent with the finding of Kwak and colleagues (2018) 
676
given the relatively crude and limited number of gray matter features, the best MAE that could be 677 achieved was 6.9 years, compared to ~4.9 years accomplished by other brain age predictors (e.g., those
678
based on spatial images with high dimensional features that may also include white matter). 12 However,
679
an advantage to using FreeSurfer data over voxelwise methods is that the fewer dimensions render our 
697
In conclusion, compared to controls, both male and female MDD patients show advanced brain aging,
698
with a subtle association with current symptom severity. This is consistent with other studies of biological 699 aging indicators in MDD at cellular and molecular levels of analysis (i.e., telomere length and epigenetic 700 age). 
